1 | advantages | 4,848 |
2 | complexities | 189 |
3 | nuances | 42 |
4 | pioneers | 26 |
5 | superiorities | 21 |
6 | virtues | 20 |
7 | protagonists | 14 |
8 | mysteries | 12 |
9 | subtleties | 12 |
10 | conundrums | 5 |
11 | data.the | 5 |
12 | triumphs | 5 |
13 | acetowhitening | 4 |
14 | age/coq10 | 4 |
15 | bargain | 3 |
16 | dominion | 3 |
17 | enterotoxicity | 3 |
18 | peripherals | 3 |
19 | presided | 3 |
20 | value-for-money | 3 |
21 | 3-cycles | 2 |
22 | cathodal-tdcs | 2 |
23 | didactically | 2 |
24 | discomfortableness | 2 |
25 | ethno-medicines | 2 |
26 | glint | 2 |
27 | mirox-arm | 2 |
28 | monocytopenia | 2 |
29 | oligohydramnions | 2 |
30 | overexpressions | 2 |
31 | pre-research | 2 |
32 | preintercalator | 2 |
33 | reification | 2 |
34 | size- | 2 |
35 | vices | 2 |
36 | vocations | 2 |
37 | 'rolled | 1 |
38 | 0.0013f/ml | 1 |
39 | 115- | 1 |
40 | 3'-ether | 1 |
41 | 3,4-dihydroxypyrrolidine-2,5-dione | 1 |
42 | 4h9-g1-ll37 | 1 |
43 | age-products | 1 |
44 | ageing-specific | 1 |
45 | alpha-group | 1 |
46 | anticonvvulsants | 1 |
47 | benefits-if | 1 |
48 | c10me10 | 1 |
49 | carcinogenic-mutagenic | 1 |
50 | commensalistic | 1 |
51 | conidiation- | 1 |
52 | countries-milnacipran | 1 |
53 | course-teachers | 1 |
54 | crepitance | 1 |
55 | dandruffcondition | 1 |
56 | de-sloughing | 1 |
57 | dioxomolybdenum | 1 |
58 | drimanes | 1 |
59 | dysarthrias | 1 |
60 | equal-access-to-care | 1 |
61 | estrogen-stimulating | 1 |
62 | four-wheeled-walker | 1 |
63 | hepatoprotectors | 1 |
64 | impactof | 1 |
65 | indicaices | 1 |
66 | left/cathode | 1 |
67 | ligand-sensing | 1 |
68 | lines/bands | 1 |
69 | lvrs-arm | 1 |
70 | mapk- | 1 |
71 | mfrcs | 1 |
72 | multilobus | 1 |
73 | non-differences | 1 |
74 | one-thirty-second | 1 |
75 | operation- | 1 |
76 | oversights | 1 |
77 | quasi-stability | 1 |
78 | smf- | 1 |
79 | spiroisoquinoline | 1 |
80 | systolic-ventricular | 1 |
81 | tumor-initiation | 1 |
82 | uterotonins | 1 |
83 | wavered | 1 |
84 | £7000 | 1 |
1 | 'rolled | 1 |
2 | 0.0013f/ml | 1 |
3 | 115- | 1 |
4 | 3'-ether | 1 |
5 | 3,4-dihydroxypyrrolidine-2,5-dione | 1 |
6 | 3-cycles | 2 |
7 | 4h9-g1-ll37 | 1 |
8 | acetowhitening | 4 |
9 | advantages | 4,848 |
10 | age-products | 1 |
11 | age/coq10 | 4 |
12 | ageing-specific | 1 |
13 | alpha-group | 1 |
14 | anticonvvulsants | 1 |
15 | bargain | 3 |
16 | benefits-if | 1 |
17 | c10me10 | 1 |
18 | carcinogenic-mutagenic | 1 |
19 | cathodal-tdcs | 2 |
20 | commensalistic | 1 |
21 | complexities | 189 |
22 | conidiation- | 1 |
23 | conundrums | 5 |
24 | countries-milnacipran | 1 |
25 | course-teachers | 1 |
26 | crepitance | 1 |
27 | dandruffcondition | 1 |
28 | data.the | 5 |
29 | de-sloughing | 1 |
30 | didactically | 2 |
31 | dioxomolybdenum | 1 |
32 | discomfortableness | 2 |
33 | dominion | 3 |
34 | drimanes | 1 |
35 | dysarthrias | 1 |
36 | enterotoxicity | 3 |
37 | equal-access-to-care | 1 |
38 | estrogen-stimulating | 1 |
39 | ethno-medicines | 2 |
40 | four-wheeled-walker | 1 |
41 | glint | 2 |
42 | hepatoprotectors | 1 |
43 | impactof | 1 |
44 | indicaices | 1 |
45 | left/cathode | 1 |
46 | ligand-sensing | 1 |
47 | lines/bands | 1 |
48 | lvrs-arm | 1 |
49 | mapk- | 1 |
50 | mfrcs | 1 |
51 | mirox-arm | 2 |
52 | monocytopenia | 2 |
53 | multilobus | 1 |
54 | mysteries | 12 |
55 | non-differences | 1 |
56 | nuances | 42 |
57 | oligohydramnions | 2 |
58 | one-thirty-second | 1 |
59 | operation- | 1 |
60 | overexpressions | 2 |
61 | oversights | 1 |
62 | peripherals | 3 |
63 | pioneers | 26 |
64 | pre-research | 2 |
65 | preintercalator | 2 |
66 | presided | 3 |
67 | protagonists | 14 |
68 | quasi-stability | 1 |
69 | reification | 2 |
70 | size- | 2 |
71 | smf- | 1 |
72 | spiroisoquinoline | 1 |
73 | subtleties | 12 |
74 | superiorities | 21 |
75 | systolic-ventricular | 1 |
76 | triumphs | 5 |
77 | tumor-initiation | 1 |
78 | uterotonins | 1 |
79 | value-for-money | 3 |
80 | vices | 2 |
81 | virtues | 20 |
82 | vocations | 2 |
83 | wavered | 1 |
84 | £7000 | 1 |
1 | 115- | 1 |
2 | size- | 2 |
3 | smf- | 1 |
4 | mapk- | 1 |
5 | conidiation- | 1 |
6 | operation- | 1 |
7 | £7000 | 1 |
8 | c10me10 | 1 |
9 | age/coq10 | 4 |
10 | 4h9-g1-ll37 | 1 |
11 | monocytopenia | 2 |
12 | ageing-specific | 1 |
13 | carcinogenic-mutagenic | 1 |
14 | commensalistic | 1 |
15 | presided | 3 |
16 | 'rolled | 1 |
17 | wavered | 1 |
18 | one-thirty-second | 1 |
19 | crepitance | 1 |
20 | left/cathode | 1 |
21 | data.the | 5 |
22 | spiroisoquinoline | 1 |
23 | 3,4-dihydroxypyrrolidine-2,5-dione | 1 |
24 | equal-access-to-care | 1 |
25 | benefits-if | 1 |
26 | impactof | 1 |
27 | de-sloughing | 1 |
28 | acetowhitening | 4 |
29 | ligand-sensing | 1 |
30 | estrogen-stimulating | 1 |
31 | pre-research | 2 |
32 | 0.0013f/ml | 1 |
33 | lvrs-arm | 1 |
34 | mirox-arm | 2 |
35 | dioxomolybdenum | 1 |
36 | countries-milnacipran | 1 |
37 | bargain | 3 |
38 | dominion | 3 |
39 | reification | 2 |
40 | tumor-initiation | 1 |
41 | dandruffcondition | 1 |
42 | alpha-group | 1 |
43 | systolic-ventricular | 1 |
44 | 3'-ether | 1 |
45 | four-wheeled-walker | 1 |
46 | preintercalator | 2 |
47 | dysarthrias | 1 |
48 | cathodal-tdcs | 2 |
49 | mfrcs | 1 |
50 | lines/bands | 1 |
51 | indicaices | 1 |
52 | vices | 2 |
53 | nuances | 42 |
54 | non-differences | 1 |
55 | advantages | 4,848 |
56 | mysteries | 12 |
57 | subtleties | 12 |
58 | superiorities | 21 |
59 | complexities | 189 |
60 | 3-cycles | 2 |
61 | drimanes | 1 |
62 | ethno-medicines | 2 |
63 | virtues | 20 |
64 | triumphs | 5 |
65 | peripherals | 3 |
66 | conundrums | 5 |
67 | uterotonins | 1 |
68 | oligohydramnions | 2 |
69 | overexpressions | 2 |
70 | vocations | 2 |
71 | pioneers | 26 |
72 | course-teachers | 1 |
73 | hepatoprotectors | 1 |
74 | discomfortableness | 2 |
75 | age-products | 1 |
76 | oversights | 1 |
77 | anticonvvulsants | 1 |
78 | protagonists | 14 |
79 | multilobus | 1 |
80 | glint | 2 |
81 | value-for-money | 3 |
82 | didactically | 2 |
83 | enterotoxicity | 3 |
84 | quasi-stability | 1 |